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Abstract The mongoose AChR K-subunit has been cloned and
shown to be highly homologous to other AChR K-subunits, with
only six differences in amino acid residues at positions that are
conserved in animal species that bind K-bungarotoxin (K-BTX).
Four of these six substitutions cluster in the ligand binding site,
and one of them, Asn-187, forms a consensus N-glycosylation
site. The mongoose glycosylated K-subunit has a higher apparent
molecular mass than that of the rat glycosylated K-subunit,
probably resulting from the additional glycosylation at Asn-187
of the mongoose subunit. The in vitro translated mongoose K-
subunit, in a glycosylated or non-glycosylated form, does not
bind K-BTX, indicating that lack of K-BTX binding can be
achieved also in the absence of glycosylation.
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1. Introduction
The nicotinic acetylcholine receptor (AChR) is a ligand-
gated cation channel that mediates synaptic transmission in
muscle and neuronal systems. The functional molecule of
muscle AChR is a pentamer with the composition of K2LQN
[1,2]. The K-subunit has been shown to contain the binding
sites for acetylcholine (ACh) and for K-bungarotoxin (K-
BTX). A⁄nity labeling experiments demonstrated that the
two adjacent cysteine residues at positions 192 and 193 of
the AChR K-subunit, are in the ACh binding site [3,4] and
other studies indicated that within the K-subunit, the ligand
binding site is located in close proximity to these two cysteines
[4^10]. Recent studies with ACh site-directed a⁄nity reactions
suggest that aromatic residues from other regions of the K-
subunit [2], as well as negatively charged amino acid residues
in the Q- and N-subunits [11^13] also participate in the agonist
binding site.
For the analysis of the binding site of muscle AChR, and in
particular for elucidating the structural requirements for K-
BTX binding, we have been studying AChRs from animal
species which are resistant to K-BTX, such as the snake [14],
mongoose [15] and hedgehog [16]. We have previously cloned,
sequenced and expressed a 250 bp fragment corresponding to
amino acid residues 122^205 of the AChR K-subunit from
these three species as well as from the mouse. The expressed
protein fragments from the snake, mongoose and hedgehog
AChR did not bind K-BTX, whereas the mouse fragment did
bind K-BTX. Sequence comparison [15,16], and analysis by
site-directed mutagenesis [17], demonstrated that amino acid
substitutions at positions 187, 189, 194 and 197 in the mon-
goose AChR K-subunit, which are conserved in the K-BTX-
sensitive animals, participate in determining the resistance to
K-BTX. It is noteworthy that in both the snake and mon-
goose, one of these substitutions (Asn-189 and Asn-187, in
the snake and mongoose, respectively [14,15]) creates a puta-
tive N-glycosylation site, which may contribute uniquely to
the resistance of these species to K-BTX [14,15,18,19].
In the present study we have cloned and sequenced the
entire mongoose AChR K-subunit gene and analyzed the gly-
cosylation potential of the translated protein and its interac-
tion with K-BTX.
2. Materials and methods
2.1. Preparation and ampli¢cation of cDNA
Mongoose muscles (Herpestes ichneumon) were obtained from the
Canadian Center of Ecological Zoology (Tel-Aviv University) and
total RNA was prepared as described [20]. cDNA and PCR were
performed as previously described [14]. The PCR reaction conditions
were as follows: one cycle of 94‡C for 3 min, and 35 cycles of 94‡C
for 2 min, 56‡C for 3 min and 72‡C for 5 min. Primer A was a sense
primer (5P-GGAATTCCACAGCCCATGGAGGCRC-3P where
R = C or T) and included an ATG (underlined) which corresponds
to the ¢rst methionine of the rat or mouse AChR K-subunit. Primer B
was an antisense primer (5P-GGAATTCTGCTCATCCTTGRTG-3P
where R = C or T) and included a stop codon (underlined). Both
primers (A and B) had an EcoRI adapter and were based on nucleo-
tides 310 to 10 (A) and 1363^1380 (complementary strand) (B) of the
rat and mouse K-subunit sequences [21,22]. The PCR fragment was
subcloned into EcoRI-digested pBluescript (Stratagene). Sequence
analysis was performed on double-stranded DNA templates on both
strands by Applied Biosystem automatic DNA sequencing facility of
the Weizmann Institute of Science. The mouse and rat K-subunit
cDNA clones were kindly provided by Dr. S. Heinemann (Salk In-
stitute, La Jolla) and Dr. V. Witzemann (Max-Planck Institut, Heidel-
berg), respectively.
2.2. In vitro translation and immunoprecipitation
Cloned cDNA encoding the mongoose, mouse and rat AChR K-
subunits were in vitro translated using the Promega TnT rabbit retic-
ulocyte lysate kit with 35S methionine (s 3000 Ci/mmole) (Amer-
sham). Following translation, samples were immunoprecipitated
with K-subunit-speci¢c anti-peptide antibodies, elicited in rabbits
against a peptide corresponding to residues 351^368 of the K-subunit
of the human AChR [23] and electrophoresed in 10% polyacrylamide
gels as described previously [24].
2.3. Binding of in vitro translated K-subunits to a-BTX-Sepharose
columns
K-BTX (Sigma, St. Louis, MO), was coupled to CNBr-activated
Sepharose 4B (Pharmacia) according to the manufacturer’s instruc-
tions. Then, 20 Wl of the 35S methionine-labeled, in vitro translated
products were applied onto K-BTX-Sepharose columns for 45 min at
room temperature. Absorption to and elution from the columns were
carried out as previously described [24].
2.4. Glycosylation of in vitro translated K-subunits
Cotranslational processing of the 35S Met-labeled proteins was car-
ried out in the presence of canine microsomal membranes (Promega).
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Treatment with 10 U/Wl Endo H (New England Biolabs) was per-
formed on the in vitro glycosylated proteins for 1 h at 37‡C in the
presence of 50 mM sodium phosphate bu¡er. The samples were elec-
trophoresed in 10% polyacrylamide gels.
3. Results
3.1. Isolation and characterization of the mongoose AChR
K-subunit cDNA clone
In order to isolate the full-length mongoose K-subunit, RT-
PCR ampli¢cation was performed using primers (see Section
2) based on the rat and the mouse sequences, starting from
the untranslated region £anking the coding region, and termi-
nating at the initiator ATG and TGA stop codons, respec-
tively. PCR on mongoose muscle cDNA resulted in ampli¢-
cation of the entire AChR K-subunit, which was cloned into
pBluescript and sequenced. This AChR K-subunit clone has
an open reading frame of 1374 bp, which translates to form a
protein of 437 residues (Fig. 1).
Alignment of the amino acid sequence of the mongoose K-
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Fig. 1. Alignment of the amino acids sequences for the mongoose, mouse and rat AChR K-subunits. The four putative transmembrane domains
(M1^M4) are marked, as well as the leader peptide. Amino acid residues at positions 112, 153, 187, 189, 194 and 197 are framed and Cys resi-
dues at positions 128, 142, 192 and 193 are bold.
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subunit with those of the mouse and rat K-subunits, shows
93% and 92% homology with these two species, respectively
(Fig. 1). Altogether, there are 29 amino acid di¡erences be-
tween the K-subunit of the mouse and the mongoose AChR,
and 35 amino acid di¡erences between the rat and the mon-
goose AChR. Only six di¡erences are at positions that are
conserved in animal species that are sensitive to K-BTX. These
six di¡erences include four residues within the binding site
domain at positions 187 (Trp to Asn), 189 (Phe to Thr),
194 (Pro to Leu) and 197 (Pro to His), and two others at
positions, 112 (Tyr to His) and 153 (Gly to Ser). Asn-187 in
the mongoose K-subunit is a putative N-glycosylation site, in
addition to the single N-glycosylation site (Asn-141), which is
present in all muscle AChR K-subunits. The other di¡erences
are at positions which are not conserved among animal spe-
cies that are susceptible to K-BTX.
3.2. Characterization of the in vitro translated mongoose
K-subunit
The mongoose, mouse and rat K-subunit cDNAs were in
vitro translated as described in Section 2. The protein prod-
ucts were immunoprecipitated speci¢cally by rabbit anti-pep-
tide antibodies speci¢c for mammalian AChRs [23]. The mon-
goose and the mouse K-subunit displayed apparent molecular
masses of 40 kDa and the rat K-subunit displayed an apparent
molecular mass of 41 kDa in SDS/polyacrylamide gel (data
not shown).
We tested the ability of the entire mongoose K-subunit to
bind K-BTX by a⁄nity chromatography on toxin columns.
The in vitro translation products of the mongoose and rat
K-subunit were applied onto K-BTX-Sepharose columns. As
depicted in Fig. 2, the mongoose K-subunit protein did not
absorb to the K-BTX column and was detected in the e¥uent,
whereas most of the rat K-subunit did absorb to the column
and could be eluted, indicating that the in vitro translated K-
subunit of the mongoose AChR does not bind K-BTX under
these conditions.
The mongoose K-subunit has two putative N-glycosylation
sites; Asn-141 that is present in all K-subunits, and Asn-187
that is unique to the mongoose K-subunit and is located with-
in the binding site domain. To follow the glycosylation pat-
tern of the mongoose K-subunit, in vitro translation was car-
ried out in the presence of canine microsomal membranes
which allow glycosylation to take place. Indeed, when in vitro
translation was carried out in the presence of microsomes, the
glycosylated mongoose K-subunit displayed a higher apparent
molecular mass of 46 kDa, and an additional band at 44 kDa,
whereas the glycosylated form of the rat K-subunit yielded
only a band of a molecular mass of 44 kDa (Fig. 3). The
higher molecular mass of the glycosylated mongoose K-sub-
unit (46 kDa) is most likely due to an additional glycosylation
at position 187. The lower band of 44 kDa may represent
incomplete glycosylation. Following deglycosylation of the
mongoose and rat glycosylated proteins with Endo H, the
molecular weights returned to the original non-glycosylated
forms (Fig. 3). The radioactive band at about 50 kDa which
is present in the samples of the mongoose K-subunit (Fig. 3a^
c) probably represents a non-related protein resulting from the
in vitro translation reaction.
4. Discussion
Cloning of the full-length mongoose K-subunit cDNA re-
veals that there are only six amino acid di¡erences in the K-
subunit of this species, at positions that are conserved among
animal species that bind K-BTX. Four of these di¡erences
cluster in the ligand binding site and include changes at posi-
tions 187 and 189 from aromatic to non-aromatic residues,
and at positions 194 and 197 from prolines to leucine and
histidine, respectively. We have shown previously by site-di-
rected mutagenesis that these four changes in the mongoose
AChR K-subunit are important in determining its lack of
binding to K-BTX [17]. The only other two substitutions at
conserved positions, throughout the entire K-subunit, are at
positions 112 (Tyr-112-His) and 153 (Gly-153-Ser). We do not
know yet whether these two changes contribute to the ligand
binding and/or channel properties of the mongoose AChR. It
is interesting to point out that in the snake AChR K-subunit
there is a change from a conserved Thr at position 111 to Asn,
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Fig. 2. Binding of in vitro translated mongoose and rat K-subunits
to K-BTX-Sepharose columns. In vitro translated 35S-Met-labeled
products of the mongoose and rat K-subunit were applied to K-
BTX-Sepharose columns. The e¥uents and the eluates (see Section
2) were electrophoresed on a 10% polyacrylamide gel and autoradio-
graphed.
Fig. 3. Glycosylation of the mongoose and the rat K-subunits. In vi-
tro translation of cloned mongoose (a^c) and rat (d^f) K-subunits
was carried out in the presence (lanes b, c, e, f) or absence (lanes a,
d) of canine microsomal membranes. The glycosylated mongoose
and rat K-subunits were treated with Endo H (lanes c, f), and were
separated on a 10% polyacrylamide gel and autoradiographed. The
arrows on the left indicate the glycosylated forms of the mongoose
(44, 46 kDa) and the arrow on the right indicates the glycosylated
form of the rat subunit (44 kDa).
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creating a potential glycosylation site [14] and suggesting that
this region (around positions 111 and 112) could be a hot spot
for mutations that may result in modi¢ed binding properties.
However, it has been demonstrated by Keller et al. [18] that
replacing Thr-111 in the mouse K-subunit for Asn, thus in-
troducing a potential glycosylation site, did not result in a
notable decrease in K-BTX binding to the receptor. As to
the Gly-153-Ser mutation in the mongoose K-subunit, it is
interesting to point out that such a mutation has been recently
reported in the human AChR K-subunit of patients with a
slow-channel congenital myasthenic syndrome and was shown
to be associated with increased ACh binding a⁄nity [25]. It
would be interesting to ¢nd out whether this change in the
mongoose AChR a¡ects its channel properties.
Asn-187 in the mongoose K-subunit [16] and Asn-189 in the
snake [14] are putative N-glycosylation sites located within the
binding domain. Although not shown yet, it is likely that
these positions are indeed glycosylated in the intact animal,
providing a bulky group at the binding site domain that in-
terferes with the interaction of AChR with K-BTX, without
a¡ecting ACh binding [16]. In the present study we have dem-
onstrated by in vitro translation experiments that Asn-187 in
the mongoose K-subunit can be glycosylated, as the glycosy-
lated mongoose K-subunit has a higher molecular mass (46
kDa) than that of the rat glycosylated K-subunit (44 kDa)
(Fig. 3). This higher molecular mass results most likely from
the additional N-glycosylation site at Asn-187 in the mon-
goose K-subunit.
The in vitro translated non-glycosylated form of the mon-
goose K-subunit did not bind K-BTX (Fig. 2), as has been also
shown by us for a fragment (residues 122^205) of this subunit
[16]. It thus seems that even in the absence of a bulky sugar
moiety, binding to K-BTX can be markedly hampered, pro-
vided that there are other appropriate substitutions. This is
also supported by our earlier study on the hedgehog AChR
[16]. In the hedgehog binding region there are two non-aro-
matic residues at positions 187 and 189 (Arg and Ile, respec-
tively), and no putative glycosylation site, like those in the
snake and mongoose. Nevertheless, the hedgehog was demon-
strated to be resistant to K-BTX administration, in compar-
ison with the mouse, though the degree of resistance was low-
er than that of the snake or mongoose. In addition, only
marginal levels of K-BTX binding to the hedgehog muscle
extract were demonstrated, and the expressed hedgehog
AChR fragment (residues 122^205 of the K-subunit) did not
bind K-BTX [16].
As stated earlier by us, there appear to be several means by
which various degrees of resistance to K-BTX have developed
during evolution. Such means include replacing aromatic res-
idues at the site by di¡erent non-aromatic ones, replacing
proline residues at the site, and introducing a glycosylation
site within the ligand binding site. It is possible that in the
intact animal, glycosylation at the binding site is an important
factor that contributes to an additional reduction in the a⁄n-
ity of K-BTX to the mongoose AChR and results in a high
level of resistance to K-BTX. This may be supported by pre-
vious binding studies on muscle extracts, showing that the
hedgehog AChR, which does not have a glycosylation site
at the ligand binding domain, exhibits a higher binding to
K-BTX than the mongoose AChR [16]. Further support for
the importance of such a glycosylation in conferring high K-
BTX resistance to the snake and mongoose, comes from site-
directed mutagenesis experiments on the mouse AChR [23,25].
These experiments demonstrated that introducing a glycosyl-
ation site into the mouse AChR K-subunit at position 187 or
189 (corresponding to the mongoose and snake glycosylation
sites) resulted in a marked decrease in K-BTX binding.
It should be noted that all highly conserved amino acid
residues in the AChR K-subunit, that were proposed to par-
ticipate in ACh binding, on the basis of a⁄nity labeling ex-
periments, namely, Tyr-93, Trp-149, Tyr-190, Cys-192, Cys-
193 and Tyr-198 [4,26^30], have been conserved in the mon-
goose K-subunit as well. It seems that the mongoose devel-
oped during evolution resistance to K-BTX by substitutions of
several amino acid residues in the AChR K-subunit, at posi-
tions that are essential for the toxin binding, though not cru-
cial for ACh binding. It would be interesting to study the
channel properties of the mongoose AChR in order to ¢nd
out whether the unique amino acid substitutions, and which
of them, have an e¡ect on the binding to ACh.
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